Journal de pharmacocinétique et thérapeutique expérimentale

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Abstrait

Pharmacokinetics Analysis of Copen, a unique anticancer Semi artificial by-product of Osthole, in Rats when Intragastric and endovenous Administration

Shentu J

Copen is one in all of the key semi artificial derivatives of osthole with apparent anticancer interest. certainly the bioavailability and gender-related pharmacokinetic properties of copen in rats were decided during this look at. Sprague-Dawley rats were intragastrically and intravenously administrated of various doses of copen, severally. The concentrations of copen in rat plasma had been decided with the aid of a LC-MS/MS methodology. Pharmacokinetic parameters had been calculable employing a drug and statistics (DAS) software system. implemented mathematics analysis become carried out victimization freelance two-sample t-check with p-values but 0.05 due to the fact the level of significance. The outcomes indicated that maximum plasma concentrations (Cmax) for copen have been finished at nine.